Likewise, Huang and colleagues, presented evidence that identifying the therapeutic targets for AKT/PI3K/mTOR axis regulation may provide interesting options for obesity treatment [42]. The gene discussed is MTOR; the disease is obesity due to melanocortin 4 receptor deficiency.